Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COSTI: Contralateral Corticosteroid Injection in Total Knee Arthroplasty
NCT06809998Phase 2Recruiting
- Sponsor
- Unity Health Toronto
- Start
- Jan 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in osteoarthritis (OA), sponsored by Unity Health Toronto. Started Jan 2025; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06809998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809998.